Vaidya Sane Ayurved Lab
MCap - 200 Cr
Investor conference Highlights
Guidance for 130-140 Cr Topline for FY25
20-30% growth guidance over the next 2 years
At Current 360 clinics
Will expand to 1000 clinics over next 2-3 years
Yes, there will be some pressure on margins, but not that much
15% EBITDA in expansion phase
After expansion we will do 20%
Expected 25% growth in Madhavprash
#Madhavbaug #stockmarkets
MCap - 200 Cr
Investor conference Highlights
Guidance for 130-140 Cr Topline for FY25
20-30% growth guidance over the next 2 years
At Current 360 clinics
Will expand to 1000 clinics over next 2-3 years
Yes, there will be some pressure on margins, but not that much
15% EBITDA in expansion phase
After expansion we will do 20%
Expected 25% growth in Madhavprash
#Madhavbaug #stockmarkets
π13